BIOMARKER R&D PROJECTS
PACIFIC
Re-defining heart failure with preserved ejection fraction (HFpEF)
MemoryLiNC
Validating clinical diagnostic performance of the best non-coding RNA panel to enable the diagnosis of early Alzheimer’s Disease
HeartLiNC
innovative IVD test to assess the risk of developing heart failure after acute myocardial infarction based on a unique profile of long non-coding RNAs
NOVACARE
a novel therapeutic antibody and a companion diagnostic test for non-ischaemic cardiac remodeling
SECRETONET
Developing new diagnostic and targeted therapeutic tools for neuroendocrine tumors
ADDIA
a reliable and non-invasive blood test for early diagnosis of Alzheimer's Disease
RABIOPRED
developing biomarkers to predict response to TNF-α inhibitors treatment of Rheumatoid Arthritis
Looking for a Research Collaboration?
sharing expertise to establish and fund innovative research projects
investing very significantly in biomarker r&d projects since 2009, today,
Firalis is a constantly sought r&d partner, including European research consortia as :
The Coordinator,
For the European Community grants in particular, Firalis has an extensive experience from the creation of project proposals including all technical, financial and commercial aspects, to establishment of a research consortium, and in all administrative steps, from project submission to overall financial and administrative coordination.
a Participant,
As a European leader SME in biomarkers and biomarker-related non-invasive diagnostic solutions, we carefully select a limited number of new projects, where we are invited to join as a project participant for European grants. We prioritize cardiovascular and neurology fields according to our core interest, and take place in few respectful consortia each year.
or a Subcontractor.
Thanks to our laboratories equipped with cutting-edge technology platforms and related technical know-how, researchers and trained technicians, also with our biobank service, altogether operating under a highest quality environment certified and accredited; Firalis is also a unique CRO service provider for all biomarker research projects.
an ACADEMIC INSTITUTE
willing to convert an IP into a product?
a PHARMA COMPANY
to subcontract a biomarker validation study?
or an SME COMPANY
looking for a partner in biomarker qualification?